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SHORT COMMUNICATION
Modulation of iV-nitrosomethylbenzylamiiie bioactivation by
diallyl sulfide in vivo
Barbara I.Ludeke, Fr£d£rk Domini, Hiroko Ofagaki
and Paul Kleihues
Institute of Neuropathology, Department of Pathology, University of Zurich,
CH-8091 Zurich, Switzerland
Diallyl sulfide (DAS), a major component of garlic oil, is an
inhibitor of tumorigenesis by various metabolkally activated
carcinogens. In rats, pretreatment with DAS has been
observed to suppress completely the induction of oesophageal
neoplasms by N-nitrosomethylbenzylamine (NMBzA)
(Wargovich et al. (1988) Cancer Res., 48, 6872-6875). This
communication reports the effects of DAS on overall NMBzA
metabolism and on DNA methylation of NMBzA in vivo under
conditions equivalent to a single treatment of the
chemoprevention assay. Male Fischer 344 rats received a
single i.g. dose of DAS (200 mg/kg body wt) followed by an
s.c. injection of [methyl-uC]NMBzA (3.5 mg/kg). In
controls, exhalation of CO2 was complete within 5 h
(t'Mma - 1-2 h). with 50% of the injected radioactivity
recovered as lH2O2. When DAS was given 3 h prior to
[methyl-I4C]NMBzA, 49% of the injected radioactivity was
released within 10 h (t>AmBX = 3 h). When DAS was
administered 18 h before the carcinogen, 42% of
[methyl-14C]NMBzA was converted to UCO2 , with
exhalation complete after 6 h (tl/unax = 1.8 h). We further
examined the effects of acute doses of 10-200 mg/kg of DAS
on DNA methylation by a single dose of NMBzA (3.5 mg/kg;
survival time, 6 h) administered 3 h later. At 200 mg/kg, DAS
inhibited the formation of O6-methyldeoxyguanosine
(O^MEdG) in oesophagus (-26%), nasal mucosa (-51%),
trachea (-68%) and lung (-78%). In liver, levels of 7-MEdG
were reduced by 43%. Decreases in DNA methylation were
proportional to dose for >25 mg/kg of DAS in oesophagus,
liver and nasal mucosa, for 25-200 mg/kg in trachea and
10-50 mg/kg in lung. The dose—activity relationship for
inhibition by DAS of DNA methylation by NMBzA suggests
that short-term modulation of carcinogen bioactivation in situ
contributes to but may not be sufficient for the chemo-
prevention of nitrosamine tumorigenesis by DAS.
Diallyl sulfide (DAS*), a major flavour and fragrance compo-
nent of garlic oil (1), has been shown to be an effective inhibitor
of tumorigenesis by diverse metabolically activated chemical
carcinogens <2—5). In the most striking example of chemopreven-
tion, Wargovich and co-workers reported (4) that pretreatment
with DAS completely prevented the formation in rat oesophagus
of both malignant and premalignant lesions by /V-nitrosomethyl-
benzylamine (NMBzA), an exceptionally potent and selective
oesophageal carcinogen in this species (6). After preadministra-
tion of DAS, a significant reduction has been observed in nuclear
aberrations induced by NMBzA and dimethylhydrazine (4,7) but
not in the nucleotoxicity of the direct-acting methylating
•Abbreviations: DAS, diallyl sulfide; NMBzA, N-nitrosomethylbenzylamine;
O^-MEdG, C^-methyldeoxyguanosine, 7-MEdG, 7-methyldeoxyguanosine.
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carcinogens /V-nitrosomethylurea and /V-methyl-/V'-nitro-/V-
nitrosoguanidine (7). Studies in vitro have shown that DAS also
is an inhibitor of oxidative metabolism by cytochrome P450
enzymes of a number of carcinogenic nitrosamines, including
NMBzA, /V-nitrosodimethylamine, /V-nitrosodiethylamine and
4-(A'-memyl-A^-nirjosarnino)-l-(3-pyridyl)-l-butanone (4,8—10).
These findings suggested that DAS may block nitrosamine-
induced tumorigenesis by inhibiting nitrosamine bioactivation
in situ. In the present investigation, we have examined this
possibility by assessing the effects of DAS on the overall
metabolism of NMBzA and on DNA methylation by NMBzA
in vivo.
In the protocol developed by Wargovich and co-workers (4),
rats received five weekly treatments consisting of an i.g. dose
of 200 mg/kg of DAS followed 3 h later by a s.c. injection of
3.5 mg/kg of NMBzA. However, in vitro demethylation of
NMBzA was significantly lower by hepatic microsomes prepared
18 h after a similar dose of DAS than by microsomes collected
3 h post-treatment (8). In order to determine whether there is
a similar difference in vivo between immediate and delayed effects
of DAS on overall NMBzA metabolism, we monitored the forma-
tion of 14CO2 and radioactive urinary metabolites from
[methyl-l4C]NMBzA administered 3 or 18 h after a single dose
of DAS. In addition, we determined the dose—activity relation-
ship of the effects of DAS on NMBzA bioactivation in target
and non-target tissues under conditions equivalent to a single treat-
ment of the chemoprevention experiment (4).
[methyl-l4C]NMBzA was synthesized according to Skipper
(11). The radiochemical purity was 83%. DAS was obtained from
Aldrich Chemical Co. (Milwaukee, WI). All other chemicals and
reagents were purchased from commercial sources described
earlier (12).
Young male Fischer 344 rats (100-140 g body wt) were
obtained from Charles River Wiga GmbH, D-8741 Sulzfeld
(Germany) and maintained on a standard laboratory diet with tap
water ad libitum. For determination of overall NMBzA
metabolism, three pairs of rats were treated with an i.g. dose
(1 ml/140 g) of corn oil (pair 1) or 200 mg/kg of DAS in corn
oil (pairs 2 and 3), followed after 3 h (pairs 1 and 2) or 18 h
(pair 3) by a single s.c. injection of [methyl-l4C]NMBzA (3.5
mg/kg; 0.49 mCi/mmol). Immediately thereafter, the animals
were placed in a metabolic cage (Jencons Metabowl, Hemel
Hempstead, UK). Exhaled 14CO2 was absorbed in two serially
connected Nilox columns, each containing 600 ml of 1 M NaOH
(13). Samples (0.5 ml) were collected hourly. Radioactivity was
determined by liquid scintillation counting (efficiency, 87.4%)
after the addition of 0.5 ml of 5 M NaOH and 10 ml of Hionic
Fluor (Packard Instruments, Zurich, Switzerland).
For studies on DNA methylation, groups of six rats were given
a single dose of 0, 10, 25, 50, 100 or 200 mg/kg of DAS in
corn oil (p.o., 1 ml/140 g), followed after 3 h by a single s.c.
injection of NMBzA (3.5 mg/kg). Animals were killed by
exsanguination under ether anaesthesia 6 h later. Tissues were
pooled (oesophagus, trachea, nasal cavity scrapings) or collected
individually Qivers, lungs, kidneys), rapidly frozen in liquid
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Fig. 1. Effects of DAS on the formation of UCO2 from /V-nitroso
[methyl-l4C]benzylamine. Animals received an i.g. dose (1 ml/140 g body
wt) of corn oil (controls) or 200 mg/kg of DAS in corn oil 3 or 18 h prior
to a single s.c. injection of W-rutroso[rnethyl-l4C]benzylaniine (3.5 mg/kg;
0.49 mCi/mmol). Data are plotted as cumulative percentages of the total
radioactivity administered.
nitrogen and stored at -10°C. DNA was isolated by automated
phenolic extraction using a Model 340A Nucleic Acid Extractor
(Applied Biosystems, Inc., Foster City, CA) as described
previously (12), except that tissue homogenates were filtered
through nylon gauze (30 /tm mesh; Willi Fischer Labortechnik,
Frankfurt/Main, Germany). Methylated deoxyguanosines were
quantitated by immuno-slot-blot assays using rabbit antiserum
NPZ-193 to O^-methyldeoxyguanosine (C^-MEdG) (14) and an
antiserum to imidazole ring-opened 7-methyldeoxyguanosine
(7-MEdG) (15) essentially as described elsewhere (16), with the
following modifications. DNA denaturation and conversion of
7-MEdG to the imidazole ring-opened form were carried out at
alkaline pH. Briefly, DNA (12 /tg in 200 /d of 1 mM
EDTA/10 mM Tris, pH 7.8) was treated with 200 /d of 100 mM
NaOH at room temperature for 10 min, neutralized by the addi-
tion of 200 /J of 15% (v/v) acetic acid, and immediately mixed
with 200 /il of 4 M ammonium acetate. Concentrations of
methylated deoxyguanosines were calculated using peak areas
of the densitometric evaluation. The limits of detection for
C^-MEdG and 7-MEdG were 0.8 and 7.5 /imol/mol dG respec-
tively.
Modulation of the overall metabolism of a single dose (3.5
mg/kg) of [methyl-l4C]NMBzA by a preceding acute dose of
DAS (200 mg/kg) is shown in Figure 1. In controls, exhalation
of I4CO2 was complete within 5 h, with 50% of the injected
radioactivity recovered as I4CO2; half of the total amount of
exhaled I4CO2 was released within 1.2 h (t,Ama]). Both the rate
and the extent of conversion of [methyl-14C]NMBzA to 14CC>2
were almost identical to those observed previously (13,18).
Recovery of radioactivity from urine after 12 h (20% of the total
administered radioactivity) was slightly higher in the present
experiment than reported previously (13), which could reflect
the excretion of polar radiolysis products of [methyl-l4C]-
NMBzA. When [methyl-14C]NMBzA was given 3 h after DAS,
formation of I4CC»2 was markedly retarded, with a total of 49%
of the administered radioactivity released within 10 h (f
 W[™» =
3 h). In contrast, production of I4CC>2 from [methyl- C]-
NMBzA administered 18 h after DAS was complete within 6 h
( % „ , = 1.8 h), whereas the fraction exhaled as I4CC>2 was
decreased to 42 %. DAS had no effect on the excretion of radio-
active urinary metabolites (data not shown).
As shown in Table I, administration of a single oral dose of
DAS (200 mg/kg) 3 h prior to an s.c. injection of NMBzA (3.5
mg/kg; survival time, 6 h) led to decreases in the formation of
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Table I. Effects of
NMBzA in various
O^-MEdG
Oesophagus
Nasal cavity
Trachea
Lung
Liver
Kidney
7-MedG
Oesophagus
Liver
a single high dose
rat tissues'
Corn oil
8.4 ± 1.4b
9.6 ± 1.0
9.1
3.2 ± 0.4
2.4 ± 0.6
1.8 ± 0.6
83.8
38.5 ± 0.1
of DAS on
DAS
6.2 ±
3.4 ±
2.9 ±
0.7 ±
2.0 ±
2.1 ±
58.2
21.8 ±
DNA
0.1
0.1
0.4
0.4
0.6
0.7
6.6
methylation by
Decrease (%)
26
51
68
78
0
0
30
43
'Adult male Fischer 344 rats received a single dose by gavage (1 ml/140 g
body wt) of either corn oil or 200 mg/kg of DAS in corn oil, followed 3 h
later by an s.c. injection of NMBzA (3.5 mg/kg; survival time, 6 h).
"Vmol/mol deoxyguanosine. Values are expressed as mean ± SD of five
animals assessed individually (liver, lung, kidney; n = 3-12) or of DNA
pooled from five animals (oesophagus, nasal mucosa, trachea; n = 3-6) .
Oeiophogus
7-iEdG
Ling -UEdG
1 10 100 1000
DAS (m«A9)
Fig. 2. Dose-dependent inhibition by DAS of DNA methylation by NMBjA
in various rat tissues. Animals received a single i.g. dose (1 ml/140 g body
wt) of 10-200 mg/kg of DAS in corn oil, followed 3 h later by a s.c.
injection of NMBjA (3.5 mg/kg). Concentrations of methylated
deoxyguanosines were determined 6 h after administration of the carcinogen.
Results are expressed as ^mol/mol deoxyguanosine. Each point represents
mean ± SD of determinations in DNA from two animals QWcr;
n = 3—12) or five animals (lung; n = 3-12) assessed individually or in
DNA pooled from five animals (oesophagus, trachea; n <= 3-6) .
C^-MEdG in oesophagus (-26%), nasal mucosa (-51%),
trachea (-68%) and lung (-78%). In liver, concentrations of
C^-MEdG were close to the limit of quantitation and a signifi-
cant effect of DAS on its formation was not observed; however,
levels of 7-MEdG were decreased by 43%. DAS did not have
a detectable effect on DNA methylation in kidney. Dose-activity
curves are shown in Figure 2. In liver and oesophagus, inhibi-
tion of DNA methylation was directly proportional to dose for
>25 mg/kg of DAS. Similar results were obtained in nasal
mucosa (data not shown). Trachea was more sensitive to the
inhibitory effects of low doses of DAS, with a dose-dependent
decrease in the formation of C^-MEdG observed for 25-200
Modulation of NMBzA bioactivation
mg/kg. In lung, there was a significant (P < 0.001) trend
towards lower levels of methylation with higher doses of DAS
for doses ranging from 10 to 50 mg/kg. The linear portions of
the double-logarithmic dose-activity curves were parallel in all
tissues.
Differential modulation of cytochrome P450 enzyme levels has
been proposed to be one of several mechanisms underlying
chemoprevention of nitrosamine tumorigenesis by DAS. In rat
liver, induction of cytochrome P4502B1, and of ethoxyresorufin
and pentoxyresorufin dealkylase activities was detected 5 h after
DAS administration, with maximum levels attained within 48 h
(8,9). Conversely, preadministration with DAS has been shown
to result in inactivation and subsequent removal from the
microsomal membrane of hepatic cytochrome P4502E1 within
18 h (8,9). We observed a decrease in both the extent and rate
of formation of 14CO2 from [methyl-14C]NMBzA given 18 h
after a single dose of DAS, suggesting that a significant reduction
of nitrosamine bioactivation may be achieved after repeated
administrations of DAS through modulation of cytochrome P450
enzyme levels in target cells. However, although NMBzA is
preferentially bioactivated in the oesophageal mucosa, measure-
ments of overall metabolism in the intact animal primarily reflect
hepatic turnover because of the size of the liver (17,18) and cannot
necessarily be extrapolated to other organs. Little is known on
the effects of DAS on monooxygenase concentrations in
extrahepatic tissues. In nasal microsomes, concentrations of
P4502E1 and proteins immunochemically related to P4502B1
were not affected by pretreatment with DAS (10). The effects
of DAS on cytochrome P450 levels in oesophagus have not yet
been reported. Stimulation of hepatic nitrosamine metabolism by
chronic administration of DAS could indirectly contribute to
chemoprevention of nitrosamine tumorigenesis in other tissues
even in the absence of an effect on extrahepatic cytochrome P450
levels by increasing first-pass clearance of nitrosamines by the
liver and hence reducing extrahepatic concentrations.
Other potentially anticarcinogenic long-term effects of DAS
that are not directly related to carcinogen bioactivation have been
described. Induction of phase II detoxification enzymes by DAS
(2,19,20), could limit the mutagenicity of a wide range of
carcinogens by stimulating conjugation and excretion of reac-
tive intermediates. In the present study, formation of urinary
metabolites from NMBzA was not significantly altered by an
acute dose of DAS administered either 3 or 18 h earlier. How-
ever, there is evidence that induction of detoxification pathways
may take longer. In mice, hepatic glutathione S-transferase
activity was increased from 118% of control levels at 24 h to
178% at 48 h after DAS administration (21). DAS has further
been shown to inhibit the induction of ornithine decarboxylase
by carcinogens (22) and 7-irradiation (23). Suppression of the
proliferative response to genotoxic damage by this or related
mechanisms has been proposed to partly account for the decrease
in tumour progression (24), in phorbol ester-induced promotion
(25,26), and in the tumorigenesis of metabolically activated and
direct-acting carcinogens (27) which were observed when DAS
or garlic extracts were administered postinitiation.
In vitro studies have revealed that DAS is a competitive
inhibitor of cytochrome P4502E1 (8). Our finding that the rate
of I4CO2 production from [methyl-l4C]NMBzA was markedly
decreased when DAS was given 3 h before the carcinogen but
only marginally affected when DAS was administered 18 h prior
to NMBzA suggests that nitrosamine metabolism in vivo is
inhibited by DAS itself or short-lived early metabolite(s). It has
recently been demonstrated (28) that DAS is completely
metabolized within 18 h in vivo. Metabolites include diallyl
sulfoxide, a competitive inhibitor of hepatic cytochrome P4502E1
in vitro, and diallyl sulfone, which has been reported to rapidly
inactivate cytochrome P4502E1 via competitive suicide inhibi-
tion (28). The time course of 14CC>2 exhalation has previously
been shown to closely parallel the overall metabolism of I4C-
labelled nitrosamines (17,29). However, modulation by DAS of
enzyme activities involved in the metabolism of the Cl pool may
have additionally inhibited the release of 14CO2.
Pretreatment with DAS led to dose-dependent inhibition of
DNA methylation by NMBzA in various rat tissues over a wide
range of doses. Nevertheless, DAS was not a very potent inhibitor
of NMBzA bioactivation. At the highest dose of DAS tested
(200 mg/kg), decreases in the extent of DNA methylation ranged
from 26% in oesophagus to 78% in lung (Table I). Levels of
methylated deoxyguanosines in oesophagus were thus only
moderately reduced when DAS and NMBzA were administered
at the same time interval and dose ratio at which, after repeated
applications, the development of preneoplastic and neoplastic
lesions was completely prevented (4). The partial inhibition of
NMBzA bioactivation is tantamount to a decrease in the effec-
tive dose of NMBzA. It has been shown (6) that even at very
small doses of genotoxic carcinogens, there is a clear dose—effect
and time relationship for tumor induction, which can be expressed
as follows:
d-f = constant; n > 1
with d being the daily dose, t the median tumour latency period
and n representing carcinogenic potency. Therefore, short-term
inhibition by DAS of NMBzA bioactivation would be expected
to significantly delay but not to prevent tumour induction by
NMBzA using the treatment protocol of the chemoprevention
assay. However, the possibility remains that multiple doses of
DAS could severely reduce the capacity for nitrosamine bioac-
tivation in this tissue if pretreatment with DAS resulted in
cumulative and persistent inactivation of oesophageal cytochrome
P450 isozymes as a consequence of slow repair or replacement.
In the chemoprevention experiments, animals were killed 15
weeks after the first treatment (4). Conceivably, NMBzA-induced
oesophageal neoplasms might have been detected had the obser-
vation period been extended to account for the increased latency
period arising from damage incurred during the initial treatment
and the decreased effective dose of carcinogen during subsequent
administrations.
In summary, our results strongly suggest that the extent to
which NMBzA bioactivation in the oesophagus was inhibited by
the immediately preceding dose of DAS during each treatment
cycle was not sufficient to elicit the complete suppression of
oesophageal tumorigenesis observed in long-term carcinogenicity
assays (4). Inhibition of bioactivation is thus very likely only one
of multiple mechanisms involved in the suppression of
nitrosamine tumorigenesis by DAS. Preliminary investigations
have suggested that at low doses of DAS, modulation of cellular
responses to genotoxic damage may predominate over effects on
carcinogen metabolism (5). This aspect of the chemopreventive
properties of DAS may be particularly relevant to human cancer
in view of the recent epidemiological study Unking consumption
of allium vegetables to a reduced incidence of gastric cancer (30).
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